Focal segmental glomerulosclerosis

Active Research Protocols

  1. 00-DK-0042 – Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study
  2. 01-DK-0053 – Permeability Factor in Focal Segmental Glomerulosclerosis
  3. 03-DK-0226 – Pulse Dexamethasone Over 48 Weeks for Podocyte Disease
  4. 05-DK-0015 – Retinoids for Podocyte Disease
  5. 06-DK-0020 – Kidney Disease Biomarkers
  6. 07-DK-0212 – Prospective Evaluation of Albuminuria in HIV Positive Patients
  7. 10-DK-0135 – Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes
  8. 11-DK-0023 – The Nephrotic Syndrome Study Network (NEPTUNE)
  9. 13-DK-0138 – A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
  10. 94-DK-0127 – Pathogenesis of Glomerulosclerosis
  11. 94-DK-0133 – Genetic Markers for Focal Segmental Glomerulosclerosis
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014